Khan Sarah, Prabhushankar Roopashree, Leary Emily, Khan Uzma Z
Sarah Khan is at the University of Missouri School of Medicine.
Roopashree Prabhushankar, MD, is at Desert Kidney Associates, Endocrinology, Mesa, Arizona.
Mo Med. 2017 Sep-Oct;114(5):387-393.
Differentiated Thyroid Cancer (DTC) is increasing in prevalence due to better diagnostic tools and excellent long-term survival. This study is to understand the outcome of twenty-six patients with DTC over a period of 10 years after the initial treatment with surgery and radioiodine therapy. Our study analysis showed no deaths, and indicated that older men were more likely to have persistent disease. Further studies are needed to focus on cost effective long-term management of DTC.
由于诊断工具的改进和出色的长期生存率，分化型甲状腺癌（DTC）的患病率正在上升。本研究旨在了解26例DTC患者在接受手术和放射性碘治疗的初始治疗后10年的预后情况。我们的研究分析显示无死亡病例，并表明老年男性更易出现持续性疾病。需要进一步开展研究，重点关注DTC具有成本效益的长期管理。
